Survival Disparity Between Antiviral-Treated and Antiviral-Naïve Patients Who Develop Their First HBV-Associated Hepatocellular Carcinoma

Daniel Garrido1, Peter Block1, Selena Lin2, Dina Halegoua-DeMarzio3, Hie-Won Hann3* 1Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA 2JBS Science Inc., Doylestown, PA, 18902, USA 3Liver Disease Prevention Center, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA *Correspondence should be addressed to Hie-Won Hann; hie-won.hann@jefferson.edu